The discovery that ZNF703 is a gene that SPRY4‐IT1 targets downstream and the demonstration that ZNF703 increases the growth of ER (−) breast cancer cells and inhibits apoptosis in vivo have both been made [149]. This evidence concerns the gene ZNF703 and breast carcinoma.